AI tools, scored for your job
Get paid to train AI
Overview Try It Reviews Integrations Why This Tool FAQ Pricing Top 10 Get Alerts News

Iktos — AI for Pharmaceutical & Biotech

Design novel, synthesizable drug candidates meeting TPP constraints efficiently.

What is Iktos?

Iktos: Design novel, synthesizable drug candidates meeting TPP constraints efficiently. Zekai's independent review scores it 6.8 out of 10. Best for accelerating early-stage drug discovery with generative AI.

Facts checked 11 Oct 2026.

DifferentiatorGenerates novel, synthesizable molecules from scratch, moving beyond traditional screening.
ProofEmpowers medicinal chemists to address stringent Target Product Profile constraints for high-quality lead candidates.
Explore Iktos
Custom – contact sales
6.8 Zekai
AI for Pharmaceutical & Biotech
Ease of Use
5.6
Accuracy
7.8
Value
6.4
Time Saving
7.2
Pharmaceutical R&D professionals can save an estimated 20-30% of their time on hit-to-lead optimization cycles through accelerated design and reduced experimental iteration.Saved / day
6.8/10Zekai Score
API Access
🏷 Is this your tool? Claim this listing →

Zekai Verdict

What is it?
Iktos is a generative AI platform designed to accelerate early-stage drug discovery.
Best for
Medicinal chemists and computational chemists engaged in early-stage drug discovery. The platform's ability to generate…
Price
Pricing on request
Zekai Score
6.8/10
Hand-scored by Zekai

Top AI for Pharmaceutical & Biotech picks

See all 21 AI tools for Pharma →
⚡ Quick answer

For pharmaceutical and biotech professionals, Iktos is a leading AI for early-stage drug discovery. Its generative AI platform goes beyond virtual screening by creating novel, synthesizable small molecules from the ground up. This allows medicinal chemists to rapidly design high-quality lead candidates optimized against complex Target Product Profiles, significantly accelerating the hit-to-lead process.

CategoryAI for Pharmaceutical & Biotech
Best forAccelerating early-stage drug discovery with generative AI.
Price fromCustom
Free planNo
DifferentiatorGenerates novel, synthesizable molecules from scratch, moving beyond traditional screening.
ProofEmpowers medicinal chemists to address stringent Target Product Profile constraints for high-quality lead candidates.
Rating6.8/10
📖 About Iktos
Watch

See Iktos in action

Prompt Templates

Try it with these prompts

Copy any prompt and paste it directly into the tool.

Design novel drug molecules

Design novel drug molecules with Makya's generative AI. Focus on synthetic accessibility and multi-parametric optimization against project objectives. Specify 3D constraints if applicable.

Plan synthesis routes

Plan efficient synthesis routes for a target compound using Spaya. Identify feasible pathways from commercially available starting materials, optimizing for your specific needs and robotic systems.

Automate drug discovery workflow

Automate the complete synthetic process from workflow management to execution using Iktos Robotics. Generate high-throughput data for iterative DMTA cycles to accelerate candidate identification.

AI Prompts

Prompts for Pharma

Prompt 01 Summarize Target-Disease Association
Act as a molecular biologist. I am investigating [[DISEASE_NAME]], a [[DISEASE_TYPE]] disorder. My proposed target is [[PROTEIN_NAME]] (UniProt: [[UNIPROT_ID]]).
Prompt 02 Generate a Target Dossier Brief
Act as a drug discovery project lead. Create a target dossier brief for [[GENE_SYMBOL]] in the context of [[THERAPEUTIC_AREA]]. The brief should be a maximum of 500 words and formatted for a slide presentation.
Prompt 03 Brainstorm Druggability Angles
My team is considering [[PROTEIN_TARGET]] for [[DISEASE]]. The protein is a [PROTEIN_CLASS, e.g., 'scaffolding protein with no known active site'].
See all 20 AI prompts for Pharma →
Social Proof

Trusted by professionals

Ease of Use
5.6
Accuracy
7.8
Value
6.4
Time Saving
7.2
Connects With

Iktos integrations

Iktos Robotics
Iktos is a generative AI platform designed to accelerate early-stage drug discovery. It creates novel, synthesizable small molecules optimized against complex pharmacological properties. This empowers medicinal chemists to move beyond virtual screening and address stringent Target Product Profile constraints for high-quality lead candidates.
Comparison

Best Iktos alternatives

Iktos vs. Schrödinger: While both platforms accelerate drug discovery, they represent different core philosophies. Schrödinger is a giant in the field, offering a comprehensive suite of physics-based modeling and machine learning tools for virtual screening and compound optimization. It excels at analyzing and refining existing chemical spaces. Iktos, however, focuses specifically on *de novo* design with its generative AI. Instead of just screening libraries, Iktos creates entirely novel, synthesizable molecules tailored to specific project profiles. This makes Iktos particularly powerful for projects requiring novel chemical matter, whereas Schrödinger provides a broader, more established computational chemistry ecosystem.

The decision

Is Iktos worth it?

Return on investment
By accelerating the hit-to-lead process, Iktos can save thousands of hours for a team of medicinal chemists, potentially bringing a drug candidate to the next phase months ahead of schedule.
Built for
Pharmaceutical R&D professionals, including medicinal chemists, computational chemists, and drug discovery scientists within pharmaceutical and biotechnology companies.
Compliance
Iktos is GDPR compliant; its broader compliance posture (HIPAA, SOC2) is not publicly documented — verify with vendor.
Who It's For

Why Pharmaceutical & Biotech choose this tool

🎯
Built for
Medicinal chemists and computational chemists engaged in early-stage drug discovery. The platform's ability to generate novel, synthesizable molecules with optimized properties directly impacts their daily workflows and the speed of lead candidate identification.
In-Depth Overview

Iktos directly addresses the core challenges faced by Pharmaceutical R&D professionals in early-stage drug discovery. Its AI-driven generative approach enables the creation of truly novel, synthesizable molecules tailored to complex project requirements, significantly accelerating the hit-to-lead process.

By moving beyond traditional screening methods, Iktos empowers scientists to explore a broader chemical space and de-risk candidate selection by inherently optimizing for multiple critical properties.

Key Use Cases

🎯
A Medicinal Chemist uses Iktos to design novel lead compounds with improved ADMET profiles
📋
⚡
A Computational Chemist uses Iktos to explore uncharted chemical space for challenging targets
🔗
💡
A Drug Discovery Project Lead uses Iktos to accelerate hit-to-lead optimization
🚀
✓ Pros
• Generates de novo small molecules with built-in synthesizability, reducing synthesis planning overhead.
• Optimizes molecules against multiple pharmacological properties simultaneously, streamlining multi-objective design.
• Moves beyond virtual screening to truly novel entity design, expanding chemical space exploration.
· Cons
• Requires significant computational resources and specialized expertise for optimal deployment.
• Custom pricing model necessitates direct engagement with sales for cost estimation.
Questions & Answers

Frequently asked questions

Does Iktos offer a free trial?

+
Iktos typically offers demonstrations and custom evaluations rather than a standard free trial. Please contact sales for options.

What is the best use for Iktos in Pharmaceutical R&D?

+
Iktos is best suited for early-stage drug discovery, specifically in de novo small molecule design and lead optimization, where rapid generation of novel, synthesizable, and multi-property optimized candidates is critical.

Does Iktos integrate with existing R&D platforms?

+
While specific integrations can vary, Iktos is designed to complement existing workflows and can often interface with common cheminformatics databases and analysis tools. Contact sales for detailed integration capabilities.

How does Iktos provide value for money?

+
Iktos provides value by significantly reducing the time and resources required for hit identification and lead optimization, accelerating the drug discovery pipeline and lowering the overall cost of bringing new therapeutics to market.
Plans & Pricing

Iktos pricing and plans

Prices and features are updated regularly but can change at any time — always confirm on the official website. Some links on this page are affiliate links.

See all 21 AI tools for Pharma →
Free guide

Take it with you

Iktos Quick Start Guide
  • What is *de novo* design?
  • Iktos vs. Traditional Screening
  • Defining the Target Product Profile (TPP)
  • Inputting Known Data & Constraints
  • Configuring the AI Model
+5 more steps inside the guide
Send me the full guide

Get Iktos deal alerts

Be the first to know when Iktos drops a new discount, adds features, or changes pricing.

Exclusive Iktos discount codes
New feature announcements
Best alternative picks when pricing changes
Zero spam — unsubscribe anytime
🎉
You're subscribed!
We'll notify you when Iktos has a new deal.
AI Directory

About Iktos

Full Description

Iktos is a generative AI platform designed to accelerate early-stage drug discovery. It creates novel, synthesizable small molecules optimized against complex pharmacological properties. This empowers medicinal chemists to move beyond virtual screening and address stringent Target Product Profile constraints for high-quality lead candidates.

Disclaimer
Zekai is an independent AI tools directory. We are not affiliated with, endorsed by, or officially connected to Iktos unless clearly stated. All product names, logos, and brands are the property of their respective owners and are used for identification purposes only. The information on this page — including pricing, features, and availability — is general information, may have changed since our last review, and is not professional advice. Zekai Scores and verdicts are our editorial opinion. Some outbound links are affiliate links that may earn us a commission at no extra cost to you. Spotted outdated or incorrect information? Request a correction →
Get paid to train AI →
‹ Previous Tool DeepCure › Next Tool Peptilogics ‹ ›
All AI Tools A–Z →
Visit website ↗
Iktos6.8Try Iktos ↗Next tool →
● 1,553 paid AI jobs open now →

See Zekai first in Google